Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Evaluating the site-specific role of GDF15 in metformin's metabolic effects
FY 2021-22
Summary
Obesity associated type 2 diabetes is characterized by a disruption in glucose homeostasis and energy balance in males and females. Metformin increases glucose tolerance and lowers body weight in rodents and humans with obesity and diabetes, but the underlying mechanisms remain unclear. Studies have documented that the glucose and weight lowering effects of metformin involved signalling pathways in the small intestine and the liver, while other organ such as the brain is known in parallel to regulate glucose and body weight. In this application, I propose to investigate whether a molecular named GDF15 plays a role in mediating the effects of metformin that involve the small intestine, liver and the brain. I will further explore the mechanism in both male and female rodents to explore for potential sex-dependent differences. These proposed studies aim to elucidate the mechanism of metformin action and unveil potential therapeutic targets to restore glucose homeostasis and energy balance in obesity-associated type 2 diabetes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466598
Name
Barros Daniel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the site-specific role of GDF15 in metformin's metabolic effects
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain; Diabetes; Feeding; Glucose; Gut; Liver; Metabolism; Metformin; Obesity; Rodents
Abstract
Obesity associated type 2 diabetes is characterized by a disruption in glucose homeostasis and energy balance in males and females. Metformin increases glucose tolerance and lowers body weight in rodents and humans with obesity and diabetes, but the underlying mechanisms remain unclear. Studies have documented that the glucose and weight lowering effects of metformin involved signalling pathways in the small intestine and the liver, while other organ such as the brain is known in parallel to regulate glucose and body weight. In this application, I propose to investigate whether a molecular named GDF15 plays a role in mediating the effects of metformin that involve the small intestine, liver and the brain. I will further explore the mechanism in both male and female rodents to explore for potential sex-dependent differences. These proposed studies aim to elucidate the mechanism of metformin action and unveil potential therapeutic targets to restore glucose homeostasis and energy balance in obesity-associated type 2 diabetes.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barros, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~